Biomark Diagnostics Develops Cancer Diagnostics Kit
Published by Canadian Investor on December 9, 2014 A newly listed company, Biomark Diagnostics,
BioMark Diagnostics Inc., providing universal access to cancer diagnostics and early stage detection by leveraging the power of new technology.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
Published by Canadian Investor on December 9, 2014 A newly listed company, Biomark Diagnostics,
Santo Sandhu, an investment advisor with Wolverton Securities, said he believes the best opportunities right
Vancouver, British Columbia – (November 17th, 2014) –BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) is pleased
Lung cancer is the deadliest cancer in North America, killing twice as many Canadians as
Call for lung cancer screening in UK View article here: http://www.bbc.com/news/health-29142822 Delays introducing lung cancer
New Urine Test Offers Early Lung Cancer Detection View article: http://lungcancernewstoday.com/2014/09/09/new-urine-test-offers-early-lung-cancer-detection/ Researchers from the University
BioMark Selected for one of the 25 spots at upcoming 48 hours at the HUB
BioMark Raman SenSers Product Launch at Strategies on Biophotonics Boston September 9-11 2014 http://pubs.rsc.org/en/Content/ArticleLanding/2014/AN/c4an01309c#!divAbstract BioMark
For more information, visit Optics Infobase: http://www.opticsinfobase.org/boe/abstract.cfm?uri=boe-5-12-4101 Or download the following PDF: boe-5-12-4101
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2
Rashid A. Bux (CEO)
[email protected]